SCHEMBL15513615

SCHEMBL15513615

CC(CCO)N[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2702508 0.79
SCHEMBL105724 0.79
SCHEMBL271756 0.77
SCHEMBL4254942 0.77 TAS1R3 (0.32)
SCHEMBL269774 0.73
SCHEMBL20657646 0.73 LMNA (0.40)
SCHEMBL2700412 0.73 KISS1R (0.32)
SCHEMBL6762829 0.72 KCNH3 (0.38)
SCHEMBL271630 0.71 ADH1B (0.50)
SCHEMBL25179 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9187487-B2 Azaindole derivatives as tyrosine kinase inhibitors PRINCIPIA BIOPHARMA, INC. (US) 2015-11-17 US claimed
US-20140073626-A1 AZAINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS Principia Biopharma (US) 2014-03-13 US claimed
US-9376438-B2 Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors PRINCIPIA BIOPHARMA, INC. (US) 2016-06-28 US disclosed
US-9187487-B2 Azaindole derivatives as tyrosine kinase inhibitors PRINCIPIA BIOPHARMA, INC. (US) 2015-11-17 US disclosed
US-20140221398-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AS TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC. (US) 2014-08-07 US disclosed
US-20140107151-A1 TYROSINE KINASE INHIBITORS Principia Biophama Inc. (US) 2014-04-17 US disclosed
US-20140073626-A1 AZAINDOLE DERIVATIVES AS TYROSINE KINASE INHIBITORS Principia Biopharma (US) 2014-03-13 US disclosed